Showing results (171-180 of 179) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Journal of Gynecologic Oncology|December 16, 2020
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancerAikou Okamoto, Eiji Kondo, Toshiaki Nakamura, et al.Journal of Gynecologic Oncology|September 9, 2024
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 studyDaisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, et al.Journal of Medical Virology|December 6, 2024
Declining Prevalence of Human Papillomavirus Co-Infections Among Young Japanese Women With Cervical Cancer and Its PrecursorsEri Yoshiizumi, Mamiko Onuki, Iwao Kukimoto, et al.Vaccines|February 26, 2022
Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination ProgramMamiko Onuki, Kasumi Yamamoto, Hideaki Yahata, et al.Cancer Treatment and Research Communications|March 7, 2026
Lenvatinib plus pembrolizumab for advanced or recurrent endometrial cancer: a retrospective multi-institutional survey in the Kinki district of JapanYasushi Mabuchi, Kyoka Takahashi, Takuya Yokoe, et al.Cancer Science|September 9, 2023
Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT studyMamiko Onuki, Fumiaki Takahashi, Takashi Iwata, et al.International Journal of Clinical Oncology|March 14, 2022
Oncologic outcomes in elderly patients who underwent hysterectomy for endometrial cancer: a multi-institutional survey in Kinki District, JapanTomohito Tanaka, Suguru Yamashita, Haruo Kuroboshi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2021
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)Junzo Hamanishi, Nobuhiro Takeshima, Noriyuki Katsumata, et al.Signal Transduction and Targeted Therapy|March 3, 2026
Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancerMeggy Suarez-Carmona, Mareike Hampel, Xin-Wen Zhang, et al.Pageof 18